Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Key features
384 or 768 cells in parallel (384 or 768 amplifier)
384 pipettor head
85 % success rates routinely obtained
Excellent results with voltage-gated & ligand-
gated ion channels
Modular approach – easy upgrade & integration
Single- and multi-hole recording substrates
Nanion Technologies
SyncroPatch 384PE - Patch Clamp gone HTS!
Dr. Markus Rapedius, Application Scientist
Measure More
Membrane
The Port-a-Patch. The world’s smallest patch clamp rig.
• Fast access to high quality patch
clamp data
• Quick evaluation of cells and
compounds
• Novel experimental possibilities
The Patchliner. Because quality does matter.
• Unlimited experimental freedom
• Best of all worlds: throughput,
performance and versatility
• Press one button and walk away:
- 48 cells in one run
The SyncroPatch 96. Get more throughput.
• Cost-efficient ion channel
screening
• Ligand- and voltage-gated
channels
• High throughput and high data
quality
The Vesicle Prep Pro. Liposomes made easy.
• Quick and easy formation of
GUVs
• Temperature control
• Stable bilayers for ephys
recordings
The Orbit 16. Instant bilayer – just add protein.
• 16 parallel bilayers
• Low noise, high bandwidth
recordings
• Compatible with your existing
amplifier
The SURFE2R. Catch the wave for transporters.
• In-depth analysis of transporter
protein activity and function
• Compatible with diverse
membrane sources
• Multiple targets investigated with
one sensor
Smart tools for ion channel and transporter research and screening
12 years of patch clamping - and more to come
The CardioExcyte 96. Bump up your safety screening.
• Ultra-precise impedance
measurements
• Real time access to beating
parameters
• Quick experiments and long term
observations
Nanion:
Stand alone machines
Higher throughput
Patch Clamping
Integration in HTS?
48
8
96
384
16
The PatchEngine – modular, compact and accessible
The PatchEngine –
the core of the SyncroPatch 384PE
Components:
Biomek FX with a 384 pipetting head
including gripper
1-2 SyncroPatch 384PE Modules
1 - 2 x 384 channel amplifier
SyncroPatch 384 software
NPC-384 borosilicate chip
Temperature controlled cell hotel
Integrated Barcode scanner
Optional 8 channel pipetting head
(Screen 100% of all compounds)
SyncroPatch 384PE – Set-up overview using the Biomek FX robot
Open design allows for seamless integration into robotic HTS-highways
Available as single and multi-hole borosilicate plates:
Single-hole substrate: Four-hole
substrate:
SyncroPatch 384 PE – Consumables NPC-384
84 % > 500 Mohm
Wellplate overview Close up
selectable traces
Experiment
statistics
One well highlighted
Current-Voltage (I/V) Relationship of hERG (CHO)
84 % > 500 Mohm
Current-Voltage (I/V) Relationship of hERG (CHO)
0
50
100
150
200
250
<5 5-10 10-15 15-20 20-25 >25
co
un
ts
C slow [pF]
0
50
100
150
200
250
300
<5 5-10 10-15 15-20 20-25
co
un
ts
R series [MΩ]
0
20
40
60
80
100
disabled (no
catch)
<100 100 - 500 >500c
ells
[%]
R seal [MΩ]
Start of experiment
End of experiment
Success rates of hERG expressed in CHO cells
Chip load &
priming
1-2 Control washes +
3 cmpd concentrations
8 – 12 minutes 5 minutes 2 minutes
Exp end &
Chip unload
Total experiment length for 4 – 5 additions: 15 – 20 minutes
Experiment length is exposure time dependent.
Experiment overview
SyncroPatch 384 PE – quick priming and short experiments
The SyncroPatch 384 PE has been validated with:
• cell lines: CHO, HEK, LTK, 1321 N1, NCL-SG3, Jurkat and RBL-1
• Cor.4U® iPSC Derived Human Cardiomyocytes
• ion channels:
• voltage-gated: hERG, Nav1.1, 1.5, 1.7, Kv1.3, Cav3.2
• ligand-gated: GABAA (α1,β2,γ2), Glycine (α1), GluA2,
P2X3, TRPA1, ASIC3, GluN1/N2B
• other: TMEM16a, Kir6.2-SUR2A, Kir2.1
SyncroPatch 384 PE – Assay compatibility examples
Voltage-gated channels (e.g. hNav 1.7)
hNav1.7 block by Tetracaine (5 µM, 50 µM and 500 µM )
CHO-hNav1.7 cells were kindly provided by Anaxon
Success rate: 92.4 %
SyncroPatch 384PE Solution Application: Mix and Read
for Voltage gated channels
cu
rre
nt
time
0
-
+
Exp length: 15 minutes
Success rate: 86.2 %
Tetracaine IC50: 49.6µM
hNav1.7 block by Tetracaine (5 µM, 50 µM and 500 µM)
CHO-hNav1.7 cells were kindly provided by Anaxon
read-out at 3 different pulses
Fast and easy analysis – more complex protocols
control 5 µM 15 µM 50 µM Tetracaine
control
5 µM
15 µM
50 µM
Effect of 0, 5, 15 and 50 mM Tetracaine
on 1st, 2nd and 10th pulse
DataControl 384: A fast and easy way of data analysis
Effect of 0, 5, 15 and 50 mM Tetracaine
on 1st, 2nd and 10th pulse
DataControl 384: A fast and easy way of data analysis
Tetracaine
1st pulse IC50 = 41.8 µM
2nd pulse IC50 = 9.9 µM
10th pulse IC50 = 3.0 µM
Current amplitude stability Seal stability
SyncroPatch 384 PE – High Quality Measurements
Inactivation stability (C1/C2)
TRPA1
TRPA1 expressed in HEKcells
The cells were kindly provided by Millipore
TRPA1 currents were initially activated by Supercinnamaldehyde (SCMA; 5 μM) and then blocked by the specific inhibitor A-967079. 242 of 283 cell were used for the IC50 analyses
TRPA1 expressed in HEKcells
74,2 % > 500 Mohm
The cells were kindly provided by Millipore
Ligand gated channels (e.g. hGABAA)
Stacked Application of solutions
for ligand-gated channels
cu
rre
nt
time
0
-
+
Repeated exposure of GABA
3x application of 2µM GABA -> stable and reproducable responses
Fast ligand gated channels (e.g. hGluA2)
Time course of stacked application
Repeated activation of HEK-hGluA2 by 300 µM Glutamate
Activation by 100 µM, 300 µM and 1 mM Glutamate
Zooming in shows an activation below 10 ms
Potassium currents through endogenous Kir 2.1-channels in RBL cells
Exp length: 15 minutes
Success rate: 90.1 %
Exchange rate: <50 ms
Fluidic Properties tested on RBL cells
Allosteric Modulation
1 µM GABA + 100 µM Pentobarbital
Allosteric Modulation of HEK-GABA by Pentobarbital
1 µM GABA
The amplitude of the allosteric modulation can be normalized to the original
amplitude of the agonist (GABA) within every individual cell.
1 µM GABA
1 µM GABA + 1 µM Pentobarbital
1 µM GABA + 10 µM Pentobarbital
1 µM GABA + 100 µM Pentobarbital
1 µM GABA + 1mM Pentobarbital
1 µM GABA + 30 µ M GABA
1 µM GABA
1 µM GABA
1 µM GABA
1 µM GABA
1 µM GABA
1 µM GABA
SyncroPatch 384 PE – Allosteric Modulation, fast and easy
HEK Gaba, 2µM GABA + 10 µ M
Ongoing project: HTS screening of Cor.4U cells!
384 scd cardiomyocytes (Cor.4U) in parallel!
Ongoing project: HTS screening of Cor.4U cells!
Ongoing project: HTS screening of Cor.4U cells!
384 scd cardiomyocytes (Cor.4U) in parallel!
The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening
Key features
384 or even 768 cells in truly parallel & modular approach
Giga-seal recordings of individually clamped cells
Up to 25,000 data points per day
85 % success rates routinely obtained
Extremely low cost per data point
Validated for diverse ion channels targets
Integrates easily into an HTS environment
Already installed in pharma, biotech, CRO + academia!
Foreign Branches: USA China Japan
Nanion Customer Reference
- a global customer base distributed between industrial and academic laboratories
Companies:
• Abbott
• Almirall Prodesfarma
• AstraZeneca
• Amgen
• Aurigene Discovery Technologies,
Ltd.
• Axiogenesis
• Bayer
• Bionomics
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Center for New Drug Safety
Evaluation and Research (NCDSER),
• Chromocell
• conoGenetix biosciences GmbH
• Evotec
• Genionics
• GlaxoSmithKline
• Grünenthal
• Hofman La Roche
• Hydra Biosciences
• Japanese Tobacco
• Lupin Limited
• Merck
• Merch Serano
• Novartis
• Novo Nordisk
• Nycomed
• Ono Pharmaceutical
• Orion Pharma
• Pfizer
• Pierre Fabre
• Regeneron Pharmaceuticals
• Rytmion
• Sanofi-Aventis
• Shinogi
• Siena Biotech
• SK Holding, Co Ltd
• Sundia MediTech Company, Ltd.
• Suven Life Sciences Ltd, Hyderabad,
India
• Syngenta
• UCB Pharma
• Vertex Pharmaceuticals
• Vimta Labs Life Sciences,
Hyderabad, India
• Wyeth
• Xention
Research institues and universites:
• Cambridge University, Cambridge, UK
• Charité - Universitätsmedizin Berlin,
Germany
• Consiglio Nazionale delle Ricerche,
Povo (Trento), Italy
• Copenhagen University, Denmark
• Cornell University, Geneva, NY, USA
• Eberhard Karls Universität Tübingen,
Germany
• FMP, Berlin, Germany
• Forschungszentrum Caesar, Bonn,
Germany
• Forschungszentrum Jülich GmbH, Jülich,
Germany
• Friedrich-Schiller-Universität Jena,
Germany
• Georg-August-Universität Göttingen,
Germany
• Griffith University, Nathan, Australia
• GSF - Forschungszentrum für Umwelt
und Gesundheit, GmbH, Neuherberg,
Germany
• Hasselt University, Diepenbeek ,Belgium
• Hertie Institute for Clinical Brain
Research, Germany
• Howard Florey Institute, USA
• Howard Hughes Medical Institute,
Ashburn, VA, USA
• Institute of Genomics and Integrative
Biology, Delhi, India
• IPBS-CNRS, Tolouse, France
• Istituto Italiano di Tecnologia, Genova,
Italy
• Jacobs University, Bremen, Germany
• JNCASR, Bangalore, India
• Julius von Sachs Institut, Würzburg,
Germany
• Karolinska Institute, Stockholm, Sweden
• Kiserleti Orvostudomanyi Kutatointezet,
Budapest, Hungary
• Korea Institute of Science and
Technology (KIST), Seoul, South Korea
• Laboratorio Especial de Toxinologia
Aplicada CAT-CEPID, Sao Paolo, Brazil
• Ludwig Maximillian Universität,
München, Germany
• Lund University, Lund, Sweden
• Max Planck Institut, Göttingen,
Germany
• Medizinische Hochschule Hannover,
Germany
Research institues and universites: (cont.)
• University of Michigan, Ann Arbor, MI,
USA
• Università degli Studi di Napoli -
Federico II, Napoli, Italy
• University of North Carolina, Wilmington,
NC, USA
• University of Queensland, Brisbane,
Australia
• University of Rochester, NY, USA
• University of Tennessee Health Science
Center, USA
• University of Valladolid and Spanish
National Research Council (CSIC),
Valladolid, Spain
• University of Washington, USA
• University of Wisconsin, Madison, WI,
USA
• Universität Zürich, Switzerland
• Universitatea Lucian Blaga din Sibiu,
Romania
• Universität Augsburg, Germany
• Universität Freiburg, Germany
• Universität für Bodenkultur, Wien, Austria
• Universität Heidelberg, Germany
• Universität Hohenheim, Germany
• Universität Osnabrück, Germany
• Vanderbilt Medical School, Nashwille,
TN, USA
• Virginia State University, Blacksburg, VA,
USA
• X-Lab, Göttingen, Germany
• Yale University, New Haven, CT, USA
• Inje University, Busan, South Korea
Research institues and universites: (cont.)
• Nanjing University, Nanjing, China
• Nanyang Technological University,
Singapore
• National University of Singapore,
Singapore
• National Center for New Drug Safety
Evaluation and Research (NCDSER),
Shanghai, China
• National Heart Center, Singapore
• National Jewish Medical and Research
Center, Denver, CO, USA
• NIH/NINDS, Bethesda, MD, USA
• NIST, Gaithersburg, MD, USA
• New York University, NY, USA
• RMIT University, Bundoora, Australia
• Ruhr-Universität Bochum, Germany
• Shanghai Institute of Materia Medica,
Shanghai, China
• Simon Fraser University, Burnaby,
Canada
• Southampton General Hospital,
Southampton, UK
• Stiftung Alfred-Wegener-Institut für
Polar- und Meeresforschung,
Bremerhaven, Germany
• Syracuse Univerity, NY, USA
• Technische Universität Ilmenau,
Germany
• Technische Universität Darmstadt,
Germany
• Technische Universiät München,
Germany
• Uppsala University, Uppsala, Sweden
• UNESCO, Bahía Blanca, Argentina
• Universidade Federal de Sao Paulo,
Brazil
• Università degli Studi di Genova, Italy
• Universitatea Lucian Blaga Din Sibiu,
Romania
• University of California, Los Angeles,
CA, USA
• University of California, San Diego, CA,
USA
• University of Cambridge, UK
• University of Cincinnati, OH, USA
• University of Groningen, the
Netherlands
• University of Leeds, UK
• Universidade de Lisboa, Portugal
Companies:
• Abbott
• Almirall Prodesfarma
• AstraZeneca
• Amgen
• Aurigene Discovery Technologies,
Ltd.
• Axiogenesis
• Bayer
• Bionomics
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Center for New Drug Safety
Evaluation and Research (NCDSER),
• Chromocell
• conoGenetix biosciences GmbH
• Evotec
• Genionics
• GlaxoSmithKline
• Grünenthal
• Hofman La Roche
• Hydra Biosciences
• Japanese Tobacco
• Lupin Limited
• Merck
• Merch Serano
• Novartis
• Novo Nordisk
• Nycomed
• Ono Pharmaceutical
• Orion Pharma
• Pfizer
• Pierre Fabre
• Regeneron Pharmaceuticals
• Rytmion
• Sanofi-Aventis
• Shinogi
• Siena Biotech
• SK Holding, Co Ltd
• Sundia MediTech Company, Ltd.
• Suven Life Sciences Ltd, Hyderabad,
India
• Syngenta
• UCB Pharma
• Vertex Pharmaceuticals
• Vimta Labs Life Sciences,
Hyderabad, India
• Wyeth
• Xention